Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Should patients with prostate cancer and a risk of nodal metastasis >1% undergo standard or limited PLND?

Nature Clinical Practice Urology volume 5, pages 10–11 (2008)Cite this article

boxed-textTouijer K et al. (2007) Standard versus limited pelvic lymph node dissection for prostate cancer in patients with a predicted probability of nodal metastasis greater than 1%. J Urol 178: 120–124

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Bader P et al. (2003) Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure? J Urol 169: 849–854

    Article  Google Scholar 

  2. Mattei A et al. (2006) Anatomic localization of prostatic sentinel lymph nodes (SLN) according to fusion imaging of SPECT and CT scans after intraprostatic injection of Technetium-99m-Nanocolloid [abstract 1388]. J Urol 175 (Suppl 4)

  3. Schumacher MC et al. (2006) Is pelvic lymph node dissection necessary in patients with a serum PSA<10 ng/ml undergoing radical prostatectomy for prostate cancer? Eur Urol 50: 272–279

    Article  Google Scholar 

  4. Daneshmand S et al. (2004) Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results. J Urol 172: 2252–2255

    Article  Google Scholar 

  5. Joslyn SA and Konety BR (2006) Impact of extent of lymphadenectomy on survival after radical prostatectomy for prostate cancer. Urology 68: 121–125

    Article  Google Scholar 

  6. Di Blasio CJ et al. (2003) Association between number of lymph nodes removed and freedom from disease progression in patients receiving pelvic lymph node dissection during radical prostatectomy for prostate cancer [abstract 1708]. J Urol 169 (Suppl 4)

Download references

Acknowledgements

The synopsis was written by Rachel Murphy, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. University Hospital of Bern, Department of Urology, Inselspital, CH-3010 Bern, Switzerland urs.studer@insel.ch

Authors and Affiliations

  1. UE Studer is a Professor and the Director of the Department of Urology, University Hospital in Bern, Switzerland.,

    Urs E Studer

Authors
  1. Urs E Studer
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Studer, U. Should patients with prostate cancer and a risk of nodal metastasis >1% undergo standard or limited PLND?. Nat Rev Urol 5, 10–11 (2008). https://doi.org/10.1038/ncpuro0943

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpuro0943

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing